Healthcare

Shares of Viromed Medical (VIROMED MEDICAL) continue to trade near their annual low at €5.20, despite the company receiving a...

Investors in BioNTech are assessing a new regulatory challenge that could impact the commercial prospects of its COVID-19 vaccine, Comirnaty,...

The biotechnology firm ImmunityBio finds itself caught between significant operational progress and mounting regulatory scrutiny. A recent official warning from...

Pharmaceutical giant Eli Lilly is strategically expanding its empire beyond its blockbuster weight-loss drugs. In a series of moves totaling...

Stryker Corporation is implementing a series of executive changes within its financial leadership team. The medical technology giant is preparing...

Eli Lilly & Company's stock posted significant gains, outperforming the broader pharmaceutical sector, following two major announcements. The company secured...

Investors in the biotech sector are closely monitoring Ocular Therapeutix as it advances through a pivotal stage of its clinical...

For investors in Achieve Life Sciences, all roads lead to a single date: June 20, 2026. This is the deadline...

BioNxt Solutions has unveiled a strategic pivot designed to position the company at the forefront of one of the pharmaceutical...

Roche has secured significant regulatory approvals across two major markets, delivering a strategic boost to its high-margin diagnostics business. The...